EDGAR Filing Documents for 0001493152-16-010569

Form 8-K - Current report:

SEC Accession No. 0001493152-16-010569

Filing Date

2016-06-07

Accepted

2016-06-07 06:06:28

Documents

Period of Report

2016-06-07

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	27323
2		ex99-1.htm	EX-99.1	25766
3		ex_001.jpg	GRAPHIC	50014
4		ex_002.jpg	GRAPHIC	176121
5		ex_003.jpg	GRAPHIC	108924
6		ex_004.jpg	GRAPHIC	80613
7		ex_005.jpg	GRAPHIC	145961
8		ex_006.jpg	GRAPHIC	83026
9		ex_007.jpg	GRAPHIC	75940
10		ex_008.jpg	GRAPHIC	105622
11		ex_009.jpg	GRAPHIC	107778
12		ex_010.jpg	GRAPHIC	107708
13		ex_011.jpg	GRAPHIC	91738
14		ex_012.jpg	GRAPHIC	106405
15		ex_013.jpg	GRAPHIC	98537
16		ex_014.jpg	GRAPHIC	72409
17		ex_015.jpg	GRAPHIC	81939
18		ex_016.jpg	GRAPHIC	77410
19		ex_017.jpg	GRAPHIC	87054
20		ex_018.jpg	GRAPHIC	54071
21		ex_019.jpg	GRAPHIC	109735
22		ex_020.jpg	GRAPHIC	69250
23		ex_021.jpg	GRAPHIC	51807
24		ex_022.jpg	GRAPHIC	41155
25		ex_023.jpg	GRAPHIC	155352
26		ex_024.jpg	GRAPHIC	157742
27		ex_025.jpg	GRAPHIC	90496
28		ex_026.jpg	GRAPHIC	73503
29		ex_027.jpg	GRAPHIC	110195
30		ex_028.jpg	GRAPHIC	70952
	Complete submission text file	0001493152-16-010569.txt		3694346

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130

Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042

Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)